#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pyruvate kinase deficiency anaemia Autoimmune disorder Metastases to central nervous system Neuromyelitis optica spectrum disorder Cystic fibrosis lung Brain stem glioma Neuroblastoma Enteritis Graft versus host disease Hereditary optic atrophy Laryngeal squamous cell carcinoma Systemic lupus erythematosus Kawasaki's disease Short-bowel syndrome Congenital disorder of glycosylation More trials…

    Learn about Rare Diseases

    Synovial sarcoma recurrent Immunodeficiency congenital – Basic Information Cytokine release syndrome – Trials in Disease Antisynthetase syndrome Turner’s syndrome – Treatment Amyotrophic lateral sclerosis – Basic Information Encephalitis autoimmune Uterine leiomyosarcoma – Basic Information Alveolar rhabdomyosarcoma – Treatment Cystic fibrosis lung – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Acetate Trihydrate Diclofenac Diethylamine Daridorexant Pacritinib Gs-5718-03 Mitazalimab Ponatinib Ecoo16 Rbl015.2 Gemcitabine Hydrochloride SP16 Arbaclofen Gad20-209-Fsp-A3 Fedratinib Trametinib Onfekafusp Alfa Somatostatin ALE.P03 Isavuconazonium Sulfate Bp1.7881A More therapies…

    Learn about Your Condition

    Colon cancer stage IV Death neonatal Impaired gastric emptying Respiratory tract infection Congenital aplastic anaemia Immune-mediated renal disorder Optic glioma Conjunctivitis allergic Tendon disorder Barrett's oesophagus Sciatica Weaning failure Stargardt's disease Cardiac failure chronic Hip fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hepatic cirrhosis

  • A Study Comparing Human Albumin and Saline Solution for Treating Kidney Injury in Patients with Advanced Liver Cirrhosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    • Sodium Chloride
    Spain

  • Study on the Effect of Carvedilol for Patients with Cirrhotic Portal Hypertension

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Carvedilol
    France

  • Study on Fecal Microbiome Transplantation for Patients with Decompensated Cirrhosis Using Allogeneic Fecal Microbiota Capsules

    Recruiting

    3 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Spain

  • Study Comparing Norfloxacin and Conventional Antibiotics for Hospitalized Patients with Decompensated Cirrhosis and Bacterial Infections

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Norfloxacin
    Spain

  • Study on Norfloxacin for Reducing Portal Hypertension in Patients with Decompensated Cirrhosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Portal hypertension
    • Hepatic cirrhosis
    Investigated Drugs:
    • Norfloxacin
    Austria

  • Study on Intestifix for Treating Immune Activation in Patients with Liver Cirrhosis and Ascites

    Recruiting

    2 1
    Investigated Drugs:
    • Intestifix
    Germany
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!